Advertisement
Screener

METAVIA INC. (MTVA) Income (Loss) from Continuing Operations before Income Taxes, Domestic

1.9 / 5 stars · 21/56 Roast Me

METAVIA INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic

METAVIA INC. (MTVA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$12.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.

Financial Statements › Income Statement › Pre-tax Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-26

  • METAVIA INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$12.97M.
  • METAVIA INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$27.59M.
  • METAVIA INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$12.47M.
  • METAVIA INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$14.56M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Domestic 12 month
2025-12-31-$12.97M
10-K · filed 2026-03-26
2024-12-31-$27.59M
10-K · filed 2026-03-26
2023-12-31-$12.47M
10-K · filed 2025-03-20
2022-12-31-$14.56M
10-K · filed 2024-03-28
2021-12-31-$14.95M
10-K · filed 2023-03-30
2020-12-31-$29.30M
10-K · filed 2022-03-31
2019-12-31-$20.93M
10-K · filed 2021-04-15
2018-12-31-$15.31M
10-K · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Dare Bioscience, Inc. (DARE)United States$0.011B
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92